Dr. Joanne Belle Rogin, MD

Dr. Rogin practices at Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota.

Dr. Rogin's NPI, 1528006418, was assigned on June 3, 2006. Dr. Rogin graduated from University of Minnesota Medical School in 1977. Dr. Rogin holds Minnesota license 25078.

Dr. Rogin's primary practice is Minneapolis Clinic of Neurology, Ltd, at 4225 Golden Valley Rd, Minneapolis, MN 55422 in Hennepin County. The practice phone is (763) 588-0661.

Dr. Rogin's primary practice is Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota. The medical group on file is Minneapolis Clinic of Neurology. Dmand AI also links Dr. Rogin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rogin practices. Vendor and product names are available with a free account.

Neurology is Dr. Rogin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rogin is licensed in Minnesota.

CMS data shows 14 Medicare services from Dr. Rogin across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $1,760 for them. Every service was in an office.

CMS counts 19 Medicare patients who saw Dr. Rogin in 2024. 58% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rogin's median patient age at 63, with 67% women.

In 2024, Dr. Rogin wrote 296 Medicare Part D claims for 45 patients. 94% of them were for generic drugs. CMS names the drug for 194 of them, across 10 drugs with 11 or more claims each, at $8,438 in total drug cost. In 2023, CMS named 332 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Rogin for performance year 2024, reported as part of a group. Dr. Rogin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Rogin, published from 2013 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Anticonvulsants, Double-Blind Method and Dibenzazepines. Dr. Rogin has published most often in Epilepsia. Dr. Rogin's most frequent co-authors are Bassel Abou-Khalil, MD, Victor Biton, MD and Veeraindar Goli, MD.

Dmand AI links Dr. Rogin to 1 clinical trial. Conditions studied include Epilepsies, Partial and Epilepsy.

CMS Open Payments shows 294 general payments to Dr. Rogin from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Sunovion Pharmaceuticals Inc. paid the most, $99,707.

Dr. Rogin graduated from University of Minnesota Medical School in 1977.